Effects of margarine supplemented with t10c12 and C9T11 CLA on atherosclerosis and steatosis in apoE/LDLR -/- mice.

The Journal of Nutrition, Health & Aging
Renata B KostogrysS Chłopicki

Abstract

The objective of this study was to evaluate functional effects of margarine supplemented with individual CLA isomers trans-10, cis-12 and cis-9, trans-11 in apoE/LDLR -/- mice. In LONG experiment (LONG), two-month old mice with no atherosclerosis were assigned to experimental groups and fed for the next 4 months. In SHORT experiment (SHORT), four-month old mice, with pre-established atherosclerosis, were assigned to experimental groups and fed for the next 2 months. The experimental diets were: AIN-93G (margarine), AIN-93G + 0.5% trans-10, cis-12 CLA (t10c12), and AIN-93G + 0.5% cis-9, trans-11 CLA (c9t11). In both experiments (LONG and SHORT), liver weight was significantly (P<0.05) increased in mice fed t10c12 CLA. Hepatic steatosis was found in animals fed t10c12 diet and no signs of the steatosis was observed in mice fed c9t11 CLA. Dietary treatments with t10c12 CLA significantly increased total plasma cholesterol and plasma triacylglycerols. There were no isomer-specific effects of CLA isomers on area of atherosclerotic plaque in aortic root. In conclusion, t10c12 CLA significantly increased liver weight in mice in LONG and SHORT experiments. Our results do not support the notion that CLA isomer supplementation to the marg...Continue Reading

References

May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·S IshibashiM S Brown
Sep 17, 2002·The Journal of Nutritional Biochemistry·Mary EvansMichael McIntosh
Sep 18, 2002·Journal of Lipid Research·Lionel ClémentPhilippe Besnard
Sep 26, 2003·The Proceedings of the Nutrition Society·Michael J Azain
Oct 22, 2003·The Journal of Clinical Investigation·Anna-Karin L RobertsonGöran K Hansson
May 26, 2004·The American Journal of Clinical Nutrition·Yanwen Wang, Peter J H Jones
May 26, 2004·The American Journal of Clinical Nutrition·Marianne O'SheaInge C M Mohede
Aug 24, 2004·The American Journal of Clinical Nutrition·Sabine TriconPhilip C Calder
Sep 6, 2005·The Journal of Nutrition·Maria Luz Fernandez, Kristy L West
Sep 27, 2005·Atherosclerosis·Sinead ToomeyOrina Belton
Aug 30, 2008·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Patricia L Mitchell, Roger S McLeod
Jul 27, 2011·Environmental Toxicology and Pharmacology·Renata B Kostogrys, Paweł M Pisulewski
May 1, 2006·Meat Science·A SchmidG Bee

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.